ACE Inhibitors

Type: Keyphrase
Name: ACE Inhibitors
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Water down your high blood pressure

By Gerald W. Deas, M.D.Until 1955, there were no drugs to control high blood pressure. Persons with this condition were in deep water and became water logged due to the retention of excess fluid. Thus, a condition known as hypertension resulted. During ... [Published Frost Illustrated - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

OVIVO relaunches with organic formula

The olive leaf supplement drink OVIVO has recently relaunched with a new organic, preservative- and sugar-free formula.The infusion combines organic olive leaf extract with calendula, grape and lemon juice, and is described as having a refreshing herbal ... [Published Natural Products Online - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

PMDA Warns Again On ARBs, ACE Inhibitors In Expectant Mothers

Article # 28140915010Posted: Sep. 16, 2014 1:05 AM GMTExecutive SummaryThe Japanese Pharmaceuticals and Medical Devices Agency on Sept. 11 warned medical personnel not to administer angiotensin II receptor blockers (ARBs) or ACE inhibitors when treating ... [Published Health News Daily - Sep 16 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 2 reports

Paradigm-Heart Failure a Possible Alternative to ACE Inhibitors

LAS VEGASThe session will focus on the late breaking trial that Drs. McMurray and Packer led over a period of five years that involved 8,400 patients with heart failure and a reduced ejection fraction from 1,043 sites throughout 47 countries. This trial ... [Published Stock Nod - Sep 15 2014]
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

Inhibiting Neprilysin Is Good for the Heart: What About the Brain?

A therapy developed by the Swiss-based pharmaceutical company Novartis could be the next big thing for congestive heart failure, a serious disease that afflicts about 5 million Americans. Called LCZ696, this drug prevented cardiovascular-related deaths ... [Published Alzheimer Research Forum - Sep 13 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Confused by Blood Test Results

I am 43 and I was diagnosed with mono back in March. I went to the dr. because I just hadn't felt very well for several weeks. I was and still am exhausted all the time, no energy. They did a mono spot test which turned out to be positive and he told ... [Published HealthBoards - Sep 12 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

PARADIGM-HF: Is It Applicable to US Patients?

Hello. This is Ileana Piña, Associate Chief of Cardiology at Montefiore Einstein Hospital and Medical Center in the Bronx, New York. Today I am in the beautiful city of Barcelona at the European Society of Cardiology (ESC) Congress. More than 30,000 individuals ... [Published General Medicine eJournal - Sep 12 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 2 reports

Example of Trial Design Data Relevant for All Stakeholders

BioCentury  has lead article this week “Betting Big on Hearts” by Emily Cukier-Meisner, Senior Writer, discussing a breakthrough drug for cardiovascular disease developed by Novartis. LCZ696 for heart failure will replace ACE inhibitors widely, so ... [Published eClinical Trends - Sep 08 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 4 reports

Combination of old and new drugs reduces CHF toll by twenty percent

Congestive heart failure (CHF) is an all-too-common cause of clinical deterioration, diminished ability to perform normal activities, and hospitalization and death. CHF is the result of numerous types of cardiac conditions, including CAD/heart attacks ... [Published American Council On Science & Health - Sep 02 2014]
First reported Sep 01 2014 - Updated Sep 02 2014 - 4 reports

Drug Gives 'New Hope' Against Heart Failure, Expert Says

By Steven ReinbergSATURDAY, Aug. 30, 2014 (HealthDay News) -- In a head-to-head comparison, an experimental drug was more effective than standard treatment at preventing deaths and hospitalizations in heart failure patients.According to the study authors, ... [Published Bio-Medicine - Sep 01 2014]
First reported Aug 31 2014 - Updated Aug 31 2014 - 3 reports

Trial shows new drug helps fight heart failure

An experimental drug has shown striking efficacy in prolonging the lives of people with heartfailure and could replace what has been the chief treatment for more than 20 years, researcherssaid yesterday.The drug being developed by the Swiss company Novartis ... [Published Columbus Dispatch - Aug 31 2014]
First reported Aug 30 2014 - Updated Aug 31 2014 - 9 reports

New drug effective in treating heart failure

An experimental drug has reduced deaths from chronic heart failure by 20 per cent compared with an existing treatment, a new study has claimed.The drug, being developed by the Swiss pharma giant Novartis, could reach the patients in the US and Europe ... [Published Business Standard India - Aug 31 2014]

Quotes

"They offer every bizarre treatment possible … They’re warning people not to get immunized."
Mark Hollis , CEO of MacPractice stated, "With this certification, we believe our customers, who prefer to use Macs and Apple native products in their practices, are well prepared to successfully demonstrate meaningful use."
Sleep is a factor in blood pressure: "People with sleep apnea tend to have more high blood pressure, and treating it improves blood pressure modestly" he says
Original Article: NEXT ARTICLE More From BioPortfolio on "PMDA Warns Again On ARBs, ACE Inhibitors In Expectant Mothers"

More Content

All (195) | News (168) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Comment: There is no "alternative medicine" [Published Special Broadcasting Service - 5 hours ago]
MacPractice MD MU Achieves ONC HIT 2014 Edition... [Published Ask.com - 10 hours ago]
Matthew J. Budoff, MD: MIBG imaging aids risk a... [Published Orthopedics Today - Sep 17 2014]
Water down your high blood pressure [Published Frost Illustrated - Sep 17 2014]
Fingertip crush injuries take longer to heal [Published STLtoday.com - Sep 17 2014]
Heal time longer on fingertip crush injuries [Published Detroit News - Sep 17 2014]
When You Learn You Have High Blood Pressure [Published PR Web via Yahoo! - Sep 16 2014]
OVIVO relaunches with organic formula [Published Natural Products Online - Sep 16 2014]
PMDA Warns Again On ARBs, ACE Inhibitors In Exp... [Published Health News Daily - Sep 16 2014]
Domestic-violence discussion Oct. 17 [Published Vindy.com - Sep 16 2014]
PMDA Warns Again On ARBs, ACE Inhibitors In Exp... [Published BioPortfolio - Sep 16 2014]
Blood Pressure-Lowering Peptides from Neo-Ferme... [Published Plosone.org - Sep 15 2014]
Paradigm-Heart Failure a Possible Alternative t... [Published Stock Nod - Sep 15 2014]
Paradigm-Heart Failure a Possible Alternative t... [Published PR Newswire: Policy & Public Interest - Sep 15 2014]
Health Check: Ace inhibitor-induced angioedema [Published TurnTo10.com - Sep 15 2014]
Amgen Presents Analyses Of Phase 3 Ivabradine D... [Published Scottrade - Sep 15 2014]
New Hyperkalemia Drug Safe, Effective in Phase ... [Published American Journal of Public Health - Sep 13 2014]
Inhibiting Neprilysin Is Good for the Heart: Wh... [Published Alzheimer Research Forum - Sep 13 2014]
Confused by Blood Test Results [Published HealthBoards - Sep 12 2014]
A Rapid-Fire Review of Four Big Trials From ESC... [Published Theheart.org - Sep 12 2014]
PARADIGM-HF: Is It Applicable to US Patients? [Published General Medicine eJournal - Sep 12 2014]
Novartis LCZ696: 'New Wonder Drug' OR 'Old Para... [Published Seeking Alpha - Sep 12 2014]
On The Pulse - 12th September 2014 [Published OnMedicanet - Sep 12 2014]
Unique Antibody Responses to Malondialdehyde-Ac... [Published Plosone.org - Sep 11 2014]
Apotex, Inc., et al. v. UCB, Inc., et al. [Published Lexology - Sep 11 2014]
St. Elizabeth Health Center Earns Get With The ... [Published PRWeb - Sep 11 2014]
Researchers from Erasmus University Medical Cen... [Published 4 Traders - Sep 11 2014]
AAFP Endorses Evidence-based Hypertension Guide... [Published American Family Physician - Sep 10 2014]
New Guidance for Managing Sickle Cell Disease [Published PT Community - Sep 10 2014]
FDA Advisors Say ‘No’ to Nebivolol/ Valsartan C... [Published PT Community - Sep 10 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Paradigm-Heart Failure a Possible Alternative t... [Published PR Newswire: Policy & Public Interest - Sep 15 2014]
LAS VEGAS, Sept. 15, 2014 /PRNewswire/ -- The Heart Failure Society of America (HFSA) will host it's 18th Annual Scientific Meeting that will feature a late breaking clinical trial which tested an Angiotensin Receptor Neprilysin inhibitor (ARNi) as a ...
Confused by Blood Test Results [Published HealthBoards - Sep 12 2014]
I am 43 and I was diagnosed with mono back in March. I went to the dr. because I just hadn't felt very well for several weeks. I was and still am exhausted all the time, no energy. They did a mono spot test which turned out to be positive and he told ...
Example of Trial Design Data Relevant for All S... [Published eClinical Trends - Sep 08 2014]
BioCentury  has lead article this week “Betting Big on Hearts” by Emily Cukier-Meisner, Senior Writer, discussing a breakthrough drug for cardiovascular disease developed by Novartis. LCZ696 for heart failure will replace ACE inhibitors widely, so ...
Logical Fallacies in Defense of the PARADIGM - ... [Published Health Care Renewal - Sep 05 2014]
We frequently discuss how commercial sponsors manipulate clinical research to serve their interests.  There have been many cases of commercially sponsored controlled trials ostensibly designed to assess their sponsors' products manipulated to make ...
Sacubitril - Valsartan, a "New Threshold of Hop... [Published Health Care Renewal - Sep 03 2014]
Summer must be over, because the next new blockbuster drug appears to be here.  At the end of August, the media heralded the results of a study of a new product for congestive heart failure (CHF) from Novartis. Novartis' New "Game Changer" The New York ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.